Suhas Darekar

440 total citations
16 papers, 261 citations indexed

About

Suhas Darekar is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Suhas Darekar has authored 16 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Suhas Darekar's work include Pluripotent Stem Cells Research (4 papers), Biochemical and Molecular Research (4 papers) and Virus-based gene therapy research (3 papers). Suhas Darekar is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), Biochemical and Molecular Research (4 papers) and Virus-based gene therapy research (3 papers). Suhas Darekar collaborates with scholars based in Sweden, Ukraine and Norway. Suhas Darekar's co-authors include Elena Kashuba, George Klein, Surya Pavan Yenamandra, Maria Yurchenko, George Simos, Georgia Chachami, Κωνσταντίνος Γεωργίου, В. И. Кашуба, Ulf Hellman and Tom Sculley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cellular and Molecular Life Sciences.

In The Last Decade

Suhas Darekar

15 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suhas Darekar Sweden	9	145	67	62	50	49	16	261
Camille Péneau France	4	144 1.0×	73 1.1×	61 1.0×	127 2.5×	41 0.8×	5	340
Richard Kirkman United States	11	221 1.5×	46 0.7×	46 0.7×	45 0.9×	57 1.2×	18	379
Tara M. Young United States	9	215 1.5×	44 0.7×	94 1.5×	55 1.1×	62 1.3×	10	350
Vignesh Gunasekharan United States	10	194 1.3×	105 1.6×	95 1.5×	109 2.2×	53 1.1×	18	334
Christine Birdwell United States	9	255 1.8×	33 0.5×	86 1.4×	41 0.8×	72 1.5×	32	421
Rena Levin-Klein Israel	9	275 1.9×	56 0.8×	54 0.9×	49 1.0×	75 1.5×	11	378
Maolin Ge China	9	146 1.0×	49 0.7×	32 0.5×	29 0.6×	45 0.9×	19	240
Jennifer A. Fairley United Kingdom	13	343 2.4×	157 2.3×	106 1.7×	90 1.8×	36 0.7×	23	532
Devathri Nanayakkara Australia	11	263 1.8×	93 1.4×	127 2.0×	23 0.5×	31 0.6×	11	382
Karl-Henning Kalland Norway	10	247 1.7×	149 2.2×	70 1.1×	17 0.3×	26 0.5×	13	402

Countries citing papers authored by Suhas Darekar

Since Specialization

Citations

This map shows the geographic impact of Suhas Darekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suhas Darekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suhas Darekar more than expected).

Fields of papers citing papers by Suhas Darekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suhas Darekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suhas Darekar. The network helps show where Suhas Darekar may publish in the future.

Co-authorship network of co-authors of Suhas Darekar

This figure shows the co-authorship network connecting the top 25 collaborators of Suhas Darekar. A scholar is included among the top collaborators of Suhas Darekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suhas Darekar. Suhas Darekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Darekar, Suhas, et al.. (2023). Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage. Heliyon. 10(1). e23831–e23831.

Alkasalias, Twana, Juan Zhang, Óscar Reina, et al.. (2022). Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells. Cell Death Discovery. 8(1). 464–464. 3 indexed citations

Darekar, Suhas & Sonia Laı́n. (2022). Asymmetric inheritance of cytoophidia could contribute to determine cell fate and plasticity. BioEssays. 44(12). e2200128–e2200128. 2 indexed citations

Zhang, Juan, Mihaela Popa, Marcus J.G.W. Ladds, et al.. (2021). DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance. iScience. 24(5). 102494–102494. 15 indexed citations

Darekar, Suhas, Alexandra Abramsson, Henrik Zetterberg, et al.. (2020). Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2. Proceedings of the National Academy of Sciences. 117(27). 15673–15683. 19 indexed citations

Darekar, Suhas, et al.. (2017). Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells. Oncotarget. 8(39). 64907–64917. 1 indexed citations

Darekar, Suhas, et al.. (2016). DNA Tumor Viruses and Cell Metabolism. Oxidative Medicine and Cellular Longevity. 2016(1). 6468342–6468342. 21 indexed citations

Darekar, Suhas, et al.. (2015). Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells. PLoS ONE. 10(8). e0136142–e0136142. 27 indexed citations

Darekar, Suhas, Sreeharsha Gurrapu, Catherine J. Drummond, et al.. (2015). Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts. Oncotarget. 6(25). 21016–21028. 14 indexed citations

10.

Yurchenko, Maria, et al.. (2013). Overexpression of MRPS18-2 in Cancer Cell Lines Results in Appearance of Multinucleated Cells. Acta Naturae. 5(1). 85–89. 4 indexed citations

11.

Снопок, Б. А., Suhas Darekar, & Elena Kashuba. (2012). Analysis of protein–protein interactions in a complex environment: capture of an analyte–receptor complex with standard additions of the receptor (CARSAR) approach. The Analyst. 137(16). 3767–3767. 8 indexed citations

12.

Darekar, Suhas, Κωνσταντίνος Γεωργίου, Maria Yurchenko, et al.. (2012). Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg Effect. PLoS ONE. 7(7). e42072–e42072. 76 indexed citations

13.

Yenamandra, Surya Pavan, Suhas Darekar, В. И. Кашуба, et al.. (2012). Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts. Cell Death and Disease. 3(1). e357–e357. 14 indexed citations

14.

Yenamandra, Surya Pavan, Ulf Hellman, Bettina Kempkes, et al.. (2010). Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cellular and Molecular Life Sciences. 67(24). 4249–4256. 33 indexed citations

15.

Kashuba, Elena, Surya Pavan Yenamandra, Suhas Darekar, et al.. (2009). MRPS18–2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties. Proceedings of the National Academy of Sciences. 106(47). 19866–19871. 20 indexed citations

16.

Sharma, Vinoda, et al.. (2006). Seroprevalence of caprine and ovine brucellosis in Mehsana and Patan districts of Gujarat.. Intas Polivet. 7(2). 316–318. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact